Pediatric Lung Transplantation

Pediatric and Congenital Heart Disease

Opinion statement

Lung transplantation in children is an effective treatment for end-stage pulmonary disease after all medical therapy has failed. It requires a huge investment in resources and absolute commitment on the part of the parents and patients. In spite of all these efforts and expense, the results with pediatric lung transplantation are the worst of all solid organ transplants. Much lies ahead to overcome the obstacles faced to improve this therapy.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Cooper JD, Ginsberg RJ, Goldberg M: The Toronto Lung Transplant Group. Unilateral transplantation for pulmonary fibrosis. N Engl J Med 1986, 314:1140–1145.CrossRefGoogle Scholar
  2. 2.•
    Aurora P, Edwards LB, Christie J, et al.: Registry of the International Society for Heart and Lung Transplantation: Twelfth official pediatric lung and heart/lung transplantation report—2009. J Heart Lung Transplant 2009, 28:1023–1030.CrossRefPubMedGoogle Scholar
  3. 3.
    Cystic Fibrosis Foundation, Patient Registry 1999 Annual Report; Bethesda Maryland; September 2000.Google Scholar
  4. 4.
    Kerem E, Reisman J, Corey M, Canny GJ, Levison H: Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187–1191.CrossRefPubMedGoogle Scholar
  5. 5.
    Robinson W, Waltz DA: FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis. Pediatr Pulmonol 2000, 30:198–202.CrossRefPubMedGoogle Scholar
  6. 6.
    Milla CE, Warwick WJ: Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998, 113:1230–1234.CrossRefPubMedGoogle Scholar
  7. 7.
    Liou TG, Adler FR, Cox DR, Cahill BC: Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007, 357:2143–2152.CrossRefPubMedGoogle Scholar
  8. 8.
    Corris PA, Christie JD: Update in transplantation 2007. Am J Respir Crit Care Med 2008, 177:1062–1067.CrossRefPubMedGoogle Scholar
  9. 9.
    D’Alonzo GE, Barst RJ, Ayres SM, et al.: Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Int Med 1991, 115:343–349.PubMedGoogle Scholar
  10. 10.
    Dimopoulos K, Inuzuka R, Goletto S, Glannakoulas G, Swan L, Sort SJ, Gatzoulis MA: Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010, 121:20–25.CrossRefPubMedGoogle Scholar
  11. 11.
    Hopkins WE, Ochoe LL, Richardson GW, Trulock EP: Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996, 15:100–105.PubMedGoogle Scholar
  12. 12.
    Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ: Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 1995, 91:2028–2035.PubMedGoogle Scholar
  13. 13.
    Canter CML, Moller JH CE, Bridges ND: Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Card 1997, 30:554–560.CrossRefGoogle Scholar
  14. 14.
    Pasque MK, Trulock EP, Cooper JD, Triantafillou AN, Huddleston CB, Rosenbloom M, Sundaresan S, Cox JL, Patterson GA: Single lung transplantation of pulmonary hypertension. Single institution experience in 34 patients. Circulation 1995, 92:2252–2258.PubMedGoogle Scholar
  15. 15.
    Osika E, Muller MH, Boccon-Gibod L, et al.: Idiopathic pulmonary fibrosis in infants. Ped Pulm 1997, 23:49–54.CrossRefGoogle Scholar
  16. 16.
    Jackson LK: Idiopathic pulmonary fibrosis. Clin Chest Med 1982, 3:579.PubMedGoogle Scholar
  17. 17.
    Novick RJ, Stitt LW, Al-Kattan K, et al.: Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Ann Thorac Surg 1998, 65:227–234.CrossRefPubMedGoogle Scholar
  18. 18.
    Sweet SC, Spray TL, Huddleston CB, Mendeloff E, Canter CE, Balzer DT, Bridges ND, Cohen AH, Mallory GB: Pediatric lung transplantation at St. Louis Children’s Hospital 1990–1995. Am J Resp Crit Care Med 1997, 155:1027–1035.PubMedGoogle Scholar
  19. 19.
    Hamvas A, Mallory GB, Spray TL, et al.: Lung transplantation for treatment of infants with surfactant protein B deficiency. J Ped 1997, 130:231–239.CrossRefGoogle Scholar
  20. 20.
    Couetil JP, Houssin DP, Soubrane O, et al.: Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1995, 110:1415–1422.CrossRefPubMedGoogle Scholar
  21. 21.
    Alexander BD, Petzold EW, Reller LB, et al.: Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 2008, 8:1025–1030.CrossRefPubMedGoogle Scholar
  22. 22.
    Kurland G: Pediatric lung transplantation: indications and contraindications. Semin Thorac Cardiovasc Surg 1996, 8:277–285.PubMedGoogle Scholar
  23. 23.
    Bumgardner GL, Hardie I, Johnson RW, et al.: Phase III Daclizumab Study Group. Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. Transplantation 2001, 72:839–845.CrossRefPubMedGoogle Scholar
  24. 24.
    Brock MV, Borja MC, Ferber L, et al.: Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant 2001, 20:1282–1290.CrossRefPubMedGoogle Scholar
  25. 25.
    Stepkowski SM, Chen H, Daloze P, Kahan BD: Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney and small bowel transplantation in the rat. Transplantation 1991, 51:22–26.CrossRefPubMedGoogle Scholar
  26. 26.
    Cooper JD, Pearson FG, Patterson GA, et al.: Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987, 93:173–181.PubMedGoogle Scholar
  27. 27.
    Ramirez J, Patterson GA: Airway complications after lung transplantation. Semin Thorac Cardiovasc Surg 1992, 4:147–153.PubMedGoogle Scholar
  28. 28.
    Ro PS, Bush DM, Kramer SS, et al.: Airway growth after pediatric lung transplantation. J Heart Lung Transplant 2001, 20:619–624.CrossRefPubMedGoogle Scholar
  29. 29.
    Sheridan PH, Cheriyan A, Doud J, Dornseif SE, Montoya A, Houck J, Flisak ME, Walsh JM, Garrity ER: Incidence of phrenic neuropathy after isolated lung transplantation. J Heart Lung Transplant 1995, 14:684–691.PubMedGoogle Scholar
  30. 30.
    Huddleston CB, Sweet SC, Mallory GB, Hamvas A, Mendeloff EN: Lung transplantation in very young infants. J Thorac Cardiovasc Surg 1999, 118:796–804.CrossRefPubMedGoogle Scholar
  31. 31.
    Gandhi SK, Bromberg BI, Mallory GB, Huddleston CB: Atrial flutter—a newly recognized complication of pediatric lung transplantation. J Thorac Cardiovasc Surg 1996, 112:984–991.CrossRefPubMedGoogle Scholar
  32. 32.
    Gandhi SK, Bromberg BI, Schuessler RB, Boineau JP, Cox JL, Huddleston CB: Left sided atrial flutter—characterization of a novel complication of pediatric lung transplantation in an acute canine model. J Thorac Cardiovasc Surg 1996, 112:992–1001.CrossRefPubMedGoogle Scholar
  33. 33.
    King RC, Binns OAR, Rodriguz F, et al.: Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000, 69:1681–1685.CrossRefPubMedGoogle Scholar
  34. 34.
    Date H, Triantafillou AN, Trulock EP, et al.: Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996, 111:913–919.CrossRefPubMedGoogle Scholar
  35. 35.
    Matsuzaki Y, Waddell TK, Puskas JD, et al.: Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1. Am Rev Respir Dis 1993, 148:882–889.PubMedGoogle Scholar
  36. 36.
    Huddleston CB, Sweet SC, Cohen AH, Mendeloff EN, Mallory GB: Bronchiolitis obliterans after pediatric lung transplantation. J Heart Lung Transplant 1998, 17:65.Google Scholar
  37. 37.
    Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA: Prevalence and outcome of bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 1995, 60:1341–1346.CrossRefPubMedGoogle Scholar
  38. 38.
    Cooper JD, Billlingham M, Egan T, et al.: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993, 12:713–716.PubMedGoogle Scholar
  39. 39.
    Novick RJ, Stitt LW, Al-Kattan K, et al.: Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Ann Thorac Surg 1998, 65:227–234.CrossRefPubMedGoogle Scholar
  40. 40.
    Walker RC, Paya CV, Marshall WF, et al.: Pretransplantation sero-negative Epstein–Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disease in adult heart, lung and other solid organ transplantation. J Heart Lung Transplant 1995, 14:214–221.PubMedGoogle Scholar
  41. 41.
    Knoop C, Kentos A, Remmelink M, et al.: Post-transplant lymphoproliferative disorders after lung transplantation: first-line treatment with rituximab may induce complete remission. Clinical Transplant 2006, 20:179–187.CrossRefGoogle Scholar
  42. 42.
    Swinnen LJ, Mullen GM, Carr TJ, Costanzo MR, Fisher RI: Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 1995, 86:3333–3340.PubMedGoogle Scholar
  43. 43.
    Papadopoulos EB, Ladanyi M, Emanuel D, et al.: Infusions of donor leukocytes to treat Epstein–Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994, 330:1185–1191.CrossRefPubMedGoogle Scholar
  44. 44.
    Rand KH, Pollard RB, Merigan TC: Increased pulmonary superinfections—cardiac transplant recipients undergoing primary cytomegalovirus infection. N Engl J Med 1987, 298:951–953.CrossRefGoogle Scholar
  45. 45.
    Cypel M, Yeung JC, Hirayama S, et al.: Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008, 27:1319–1325.CrossRefPubMedGoogle Scholar
  46. 46.
    Puri V, Scavuzzo M, Guthrie T, et al.: Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg 2009, 88:1609–1614.CrossRefPubMedGoogle Scholar
  47. 47.
    De Oliveira NC, Osaki S, Maloney JD, et al.: Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center. J Thorac Cardiovasc Surg 2010, 139:1306–1315.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Children’s HospitalSt. LouisUSA

Personalised recommendations